Search Results

240 results for CELG

Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen

By William White, InvestorPlace Writer

Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.

Trade of the Day: Celgene (CELG) Stock is a Stellar Buy at $100

By Sam Collins, InvestorPlace Chief Technical Analyst

A pullback should provide a great entry point.

Celgene on the Verge of a Bull Channel Breakout

By Sam Collins, InvestorPlace Chief Technical Analyst

Celgene (CELG) is in a powerful bull channel with support at its 50-day moving average.

Sharp Drop Celgene Corporation Stock May Have Just Created an Entry Point

By Chris Lau, InvestorPlace Contributor

Investors are so wary of Celgene’s prospects that they overlook the steady growth ahead and potential for CELG stock after 2020.

3 Beaten-Down Biotech Stocks to Buy for Huge Gains

By Ryan Fuhrmann, InvestorPlace Contributor

The following are three Biotech stocks to buy because of their long-term potential, which surpasses the recent onslaught of negative press and concern over higher…

Put This Biotech at the Top of Your Must-Buy List on a Pullback

By Sam Collins, InvestorPlace Chief Technical Analyst

Celgene Corp. (CELG) is in a powerful bull channel with support roughly at its 50-day moving average.

Overbought Biotech Still a Good Buy

By Sam Collins, InvestorPlace Chief Technical Analyst

Celgene Corp.’s breakout is so strong that it could remain overbought for some time. Get the target.

7 Battered Biotech Stocks: Bargains or Busts?

By Brian Nichols, InvestorPlace Contributor

Biotech stocks have suffered big losses in 2016. Some are great buying opportunities, but the rest are just disasters.

Why Now Is the Perfect Time to Short Juno Therapeutics Inc Stock

By Nicolas Chahine, InvestorPlace Contributor

A 50% pop on speculation is as good a reason to short JUNO stock as any. This is how you should play Juno Therapeutics now.

3 Bear Plays for the Bust in Biotech Stocks

By Tyler Craig, Tales of a Technician

The bull in biotech stocks is dead. Embrace the new bearish overlords with put plays on these three biotechs.

Celgene Corporation Stock Pops on Q1 Earnings Beat

By William White, InvestorPlace Writer

Celgene (CELG) stock was up on Friday following the release of its positive earnings report for the first quarter of the year.

3 Biotech Stocks to Sell Now

By Tyler Craig, Tales of a Technician

A bear raid has descended on biotech stocks. Here’s how to capitalize on continued pain in BIIB, CELG and ALXN.

5 Top Stock Trades for Tuesday Morning

By Bret Kenwell, InvestorPlace Contributor

U.S. and China are seemingly playing ball — for now — when it comes to trade negotiations. That’s got stocks in rally mode. Here are…

3 Biotech Trades to Diversify Your Portfolio

By Chris Tyler, InvestorPlace Contributor

There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks.

3 Ways to Play This Biotech Stocks Dip

By Tyler Craig, Tales of a Technician

Biotech stocks have retraced to an attractive buy point. Consider these three plays on XBI, CELG and AMGN.

Friday’s Vital Data: Twitter Inc (TWTR), Microsoft Corporation (MSFT) and Celgene Corporation (CELG)

By Joseph Hargett, InvestorPlace Contributor

Twitter (TWTR) options surge on good report, Microsoft (MSFT) earnings soar in the clouds and Celgene (CELG) cuts guidance.

Why OHR Pharmaceutical (OHRP), Macy’s (M) and Celgene (CELG) are 3 of Today’s Best Stocks

By John Divine, InvestorPlace Assistant Editor

OHR Pharmaceutical (OHRP), Macy’s (M) and Celgene (CELG) each bucked the bearish tone on Wall Street today, ending as big winners.

3 Large-Cap Biotech Stocks to Scrape From the Selloff

By Chris Tyler, InvestorPlace Contributor

Large-cap biotech stocks like Regeneron, Celgene and Amgen are offering value both on and off the price chart. Here’s how to profit.

Negativity Is Building on Celgene Corporation Ahead of Earnings But You Can Still Profit

By Joseph Hargett, InvestorPlace Contributor

Celgene has beaten earnings expectations in the past four quarters. Can another earnings beat shake off the recent spike in negativity?

5 Top Stock Trades for Tuesday: CELG, BMY, CZR

By Bret Kenwell, InvestorPlace Contributor

Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.

3 Biotech Stocks That Are Just Getting Started

By Tyler Craig, Tales of a Technician

Biotech stocks are leading the charge in this bull market. And last week’s drop is a golden opportunity for buying these three beauties.

Celgene vs. Gilead Stock: What’s the Better Biotech Buy?

By Bret Kenwell, InvestorPlace Contributor

Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?

Get This Blazing Hot Biotech for a Reasonable Price

By Sam Collins, InvestorPlace Chief Technical Analyst

A consolidation in Celgene Corp. is giving traders the perfect opportunity to buy at a bargain.

3 Undervalued Biotech Stocks To Buy

By Josh Enomoto, InvestorPlace Contributor

Despite the sharp correction in the heath care sector, these three biotech stocks should recover off of their strong fundamentals.

5 – 10 of 240 results